Alzheimer’s treatment Leqembi could cost Medicare up to $5 billion per year, study estimates

The authors said the estimated costs of Leqembi to Medicare are conservative and spending on the Alzheimer’s treatment may increase more than anticipated.

This article was originally published on CNBC